These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3296684)

  • 1. Metabolism of apolipoprotein C: kinetic studies in human subjects: a critical review.
    Malmendier CL; Lontie JF; Grutman G; Delcroix C
    Adv Exp Med Biol; 1987; 210():95-103. PubMed ID: 3296684
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects.
    Malmendier CL; Lontie JF; Grutman GA; Delcroix C
    Atherosclerosis; 1986 Nov; 62(2):167-72. PubMed ID: 3099803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of apolipoprotein C-III in normolipemic human subjects.
    Malmendier CL; Lontie JF; Grutman GA; Delcroix C
    Atherosclerosis; 1988 Jan; 69(1):51-9. PubMed ID: 3355607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular variants of the lipoproteins.
    Galton DJ; Stocks J; Rees A
    Clin Sci (Lond); 1983 Jun; 64(6):559-63. PubMed ID: 6404583
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
    Jong MC; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):472-84. PubMed ID: 10073946
    [No Abstract]   [Full Text] [Related]  

  • 6. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
    Jong MC; Havekes LM
    Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro.
    Jahn CE; Osborne JC; Schaefer EJ; Brewer HB
    Eur J Biochem; 1983 Mar; 131(1):25-9. PubMed ID: 6403350
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis.
    Nestel PJ; Huff MW; Billington T; Fidge NH
    Biochim Biophys Acta; 1982 Jul; 712(1):94-102. PubMed ID: 7115750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoproteins A and C; interaction with lipid monolayers.
    Jackson RL; Pattus F; de Haas G; Demel RA
    Ann N Y Acad Sci; 1980; 348():75-86. PubMed ID: 6772080
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation of the apoprotein components of human very low density lipoproteins by ion-paired, reversed-phase high performance liquid chromatography.
    Hancock WS; Bishop CA; Gotto AM; Harding DR; Lamplugh SM; Sparrow JT
    Lipids; 1981 Apr; 16(4):250-9. PubMed ID: 7242277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of heterogeneous populations of particles.
    Malmendier GL; Lontie JF; Delcroix C; Dubois DY
    Adv Exp Med Biol; 1991; 285():223-32. PubMed ID: 1858552
    [No Abstract]   [Full Text] [Related]  

  • 13. [The metabolism and function of apolipoprotein C-III].
    Ebara T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():125-30. PubMed ID: 11351559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on duck serum lipoproteins. VIII. Studies on biological activity and metabolism of HDL-apo C II in vitro].
    Li XZ; Wang KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Apr; 9(2):89-94. PubMed ID: 2955931
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
    Liu BW; Hynd BA; Kashyap ML
    Biochem Biophys Res Commun; 1984 Jun; 121(3):946-52. PubMed ID: 6588972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of apolipoproteins AI, CI, CII, CIII and E on the binding of 125I-labeled apoE-deficient HDL3 to rat liver plasma membranes].
    Zhang L; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):120-3. PubMed ID: 1664812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
    Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins C-I, C-II, and C-III: kinetics of association with model membranes and intermembrane transfer.
    McKeone BJ; Massey JB; Knapp RD; Pownall HJ
    Biochemistry; 1988 Jun; 27(12):4500-5. PubMed ID: 3166993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apolipoprotein C-I, C-II, C-III].
    Fukushima N; Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():110-3. PubMed ID: 15658276
    [No Abstract]   [Full Text] [Related]  

  • 20. Turnover and interconversion of LDL sub-fractions.
    Thompson GR; Kano M; Reeve J
    Adv Exp Med Biol; 1987; 210():105-9. PubMed ID: 3591541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.